AvalehtHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Viimane sulgemishind
25,60 €
Tänane vahemik
25,80 € - 25,80 €
Aasta vahemik
21,00 € - 28,80 €
Turuväärtus
364,25 mld JPY
Keskmine maht
6,00
P/E suhe
-
Dividendimäär
-
Põhibörs
TYO
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(JPY) | aug 2024info | Y/Y muutus |
---|---|---|
Käive | 39,65 mld | 13,66% |
Põhitegevusega seonduv kulu | 18,75 mld | 17,95% |
Puhastulu | 4,31 mld | −1,33% |
Puhaskasumimarginaal | 10,87 | −13,18% |
Puhaskasum aktsia kohta | — | — |
EBITDA | 6,35 mld | 20,49% |
Tõhus maksumäär | 28,38% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(JPY) | aug 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 122,74 mld | −13,22% |
Kogu vara | 350,48 mld | 1,79% |
Kõik kohustused | 74,55 mld | 7,74% |
Kogu omakapital | 275,92 mld | — |
Emiteeritud aktsiate arv | 73,34 mln | — |
Hinna ja väärtuse suhe P/B | 0,01 | — |
Varade tasuvus | 3,52% | — |
Kapitali tasuvus | 4,46% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(JPY) | aug 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 4,31 mld | −1,33% |
Põhitegevuse rahakäive | — | — |
Investeeringute raha | — | — |
Finantseerimise raha | — | — |
Raha ja raha ekvivalentide muutus | — | — |
Tasuta rahavoog | — | — |
Teave
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Asutatud
1847
Peakontor
Veebisait
Töötajate arv
2 759